Literature DB >> 17917025

Matched unrelated bone marrow transplant for severe combined immunodeficiency.

Chaim M Roifman1, Eyal Grunebaum, Ilan Dalal, Luigi Notarangelo.   

Abstract

Severe combined immunodeficiency (SCID) is a lethal disease unless allogeneic bone marrow transplantation (BMT), preferably from a family related HLA identical donor (RID) is given. Previously, some patients received HLA-mismatched related donors (MMRD) BMT, which often resulted in slow immune reconstitution and variable survival. Alternatively, HLA-matched unrelated donors (MUD) BMT have been suggested. Recently, we have directly compared outcome of patients with SCID who received either MMRD or MUD BMT. Survival after MUD BMT was significantly better than after MMRD BMT. Patients who received MUD BMT also had better engraftment of donor cells and immune reconstitution. Recent reports from other centers confirm these results finding that MUD BMT provides excellent survival and better immune reconstitution for patients with SCID. In conclusion, MUD BMT appears vastly superior to MMRD BMT and should be offered as first choice of treatment for patients with SCID when RID is unavailable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917025     DOI: 10.1007/s12026-007-0042-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  34 in total

1.  Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.

Authors:  A Lanfranchi; R Verardi; K Tettoni; A Neva; E Mazzolari; M Pennacchio; S Pasic; A G Ugazio; A Albertini; F Porta
Journal:  Haematologica       Date:  2000-11       Impact factor: 9.941

2.  Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts.

Authors:  William R Drobyski; John Klein; Neal Flomenberg; Daniel Pietryga; David H Vesole; David A Margolis; Carolyn A Keever-Taylor
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.

Authors:  L M Ball; A C Lankester; R G M Bredius; W E Fibbe; M J D van Tol; R M Egeler
Journal:  Bone Marrow Transplant       Date:  2005-03       Impact factor: 5.483

Review 4.  Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation.

Authors:  Marina Cavazzana-Calvo; Isabelle André-Schmutz; Salima Hacein-Bey-Abina; Danielle Bensoussan; Françoise Le Deist; Alain Fischer
Journal:  Semin Hematol       Date:  2002-01       Impact factor: 3.851

5.  Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

Authors:  D D Patel; M E Gooding; R E Parrott; K M Curtis; B F Haynes; R H Buckley
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

6.  Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.

Authors:  A H Filipovich; R S Shapiro; N K Ramsay; T Kim; B Blazar; J Kersey; P McGlave
Journal:  Blood       Date:  1992-07-01       Impact factor: 22.113

7.  Mutation analysis should be performed to rule out gammac deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests.

Authors:  Raz Somech; Chaim M Roifman
Journal:  J Pediatr       Date:  2005-10       Impact factor: 4.406

Review 8.  Trends in transplantation of hematopoietic stem cells from unrelated donors.

Authors:  C Anasetti; E W Petersdorf; P J Martin; A Woolfrey; J A Hansen
Journal:  Curr Opin Hematol       Date:  2001-11       Impact factor: 3.284

9.  Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donors.

Authors:  S Caillat-Zucman; F Le Deist; E Haddad; M Gannagé; L Dal Cortivo; N Jabado; S Hacein-Bey-Abina; S Blanche; J-L Casanova; A Fischer; M Cavazzana-Calvo
Journal:  Bone Marrow Transplant       Date:  2004-06       Impact factor: 5.483

Review 10.  Advances in the understanding and treatment of human severe combined immunodeficiency.

Authors:  R H Buckley
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

View more
  8 in total

1.  Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey.

Authors:  Alice Chan; Christopher Scalchunes; Marcia Boyle; Jennifer M Puck
Journal:  Clin Immunol       Date:  2010-10-28       Impact factor: 3.969

2.  T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.

Authors:  Tony Z Xiao; Kanal Singh; Elizabeth Dunn; Rageshree Ramachandran; Morton J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-19       Impact factor: 5.742

3.  Genotype, phenotype, and outcomes of nine patients with T-B+NK+ SCID.

Authors:  Grace P Yu; Kari C Nadeau; David R Berk; Geneviève de Saint Basile; Nathalie Lambert; Perrine Knapnougel; Joseph Roberts; Kristina Kavanau; Elizabeth Dunn; E Richard Stiehm; David B Lewis; Dale T Umetsu; Jennifer M Puck; Morton J Cowan
Journal:  Pediatr Transplant       Date:  2011-08-23

4.  Single-center analysis of long-term outcome after hematopoietic cell transplantation in children with congenital severe T cell immunodeficiency.

Authors:  Evelina Mazzolari; Donatella de Martiis; Concetta Forino; Arnalda Lanfranchi; Silvia Giliani; Roberto Marzollo; Paolo Airò; Luisa Imberti; Fulvio Porta; Luigi D Notarangelo
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

5.  Tryptic peptide screening for primary immunodeficiency disease by LC/MS-MS.

Authors:  Sandra A Kerfoot; Sunhee Jung; Karin Golob; Troy R Torgerson; Si Houn Hahn
Journal:  Proteomics Clin Appl       Date:  2012-08       Impact factor: 3.494

6.  Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.

Authors:  Vicki Modell; Megan Knaus; Fred Modell; Chaim Roifman; Jordan Orange; Luigi D Notarangelo
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

7.  Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature.

Authors:  Sarah Schober; Karin Schilbach; Michaela Doering; Karin M Cabanillas Stanchi; Ursula Holzer; Patrick Kasteleiner; Jens Schittenhelm; Juergen F Schaefer; Ingo Mueller; Peter Lang; Rupert Handgretinger
Journal:  BMC Pediatr       Date:  2019-10-11       Impact factor: 2.125

Review 8.  Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options.

Authors:  Suk See De Ravin; Harry L Malech
Journal:  Immunol Res       Date:  2009       Impact factor: 4.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.